Therapeutic antibodies and infectious diseases, Tours, France, November 20−22, 2012
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic antibodies and infectious diseases, Tours, France, November 20−22, 2012
Authors
Keywords
-
Journal
mAbs
Volume 5, Issue 5, Pages 626-632
Publisher
Informa UK Limited
Online
2013-06-07
DOI
10.4161/mabs.25300
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The high-affinity human IgG receptor Fc RI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy
- (2013) D. A. Mancardi et al. BLOOD
- An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission
- (2013) Alexander W. Tarr et al. HEPATOLOGY
- Properties of mouse and human IgG receptors and their contribution to disease models
- (2012) P. Bruhns BLOOD
- Outbreak of Shiga Toxin-Producing Escherichia coli O104:H4 Associated With Organic Fenugreek Sprouts, France, June 2011
- (2012) L. A. King et al. CLINICAL INFECTIOUS DISEASES
- Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa
- (2012) Bruno François et al. CRITICAL CARE MEDICINE
- Universal vaccine against influenza virus: Linking TLR signaling to anti-viral protection
- (2012) Nicole Schmitz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination
- (2012) Muhammad N. Zahid et al. HEPATOLOGY
- Targeting Pan-Resistant Bacteria With Antibodies to a Broadly Conserved Surface Polysaccharide Expressed During Infection
- (2012) David Skurnik et al. JOURNAL OF INFECTIOUS DISEASES
- Passive immunity in the prevention of rabies
- (2012) Leonard Both et al. LANCET INFECTIOUS DISEASES
- HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
- (2012) Florian Klein et al. NATURE
- Staphylococcus aureus Isolates Encode Variant Staphylococcal Enterotoxin B Proteins That Are Diverse in Superantigenicity and Lethality
- (2012) Petra L. Kohler et al. PLoS One
- Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease
- (2012) J. M. Dye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
- (2012) B. Moldt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study
- (2012) J. Menne et al. BMJ-British Medical Journal
- Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY-1
- (2011) Carmen Bozic et al. ANNALS OF NEUROLOGY
- A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection
- (2011) Marcella Visentini et al. AUTOIMMUNITY REVIEWS
- Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic use
- (2011) Torben P. Frandsen et al. BIOTECHNOLOGY AND BIOENGINEERING
- Human Fc RIIA induces anaphylactic and allergic reactions
- (2011) F. Jonsson et al. BLOOD
- Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia
- (2011) Q. Lu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Broad neutralization coverage of HIV by multiple highly potent antibodies
- (2011) Laura M. Walker et al. NATURE
- Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
- (2011) P. Vermersch et al. NEUROLOGY
- A Neutralizing Human Monoclonal Antibody Protects African Green Monkeys from Hendra Virus Challenge
- (2011) K. N. Bossart et al. Science Translational Medicine
- A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
- (2010) F. Vincenti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry
- (2010) D. Salmon-Ceron et al. ANNALS OF THE RHEUMATIC DISEASES
- Preclinical In Vitro and In Vivo Characterization of the Fully Human Monoclonal IgM Antibody KBPA101 Specific for Pseudomonas aeruginosa Serotype IATS-O11
- (2010) M. P. Horn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease
- (2010) A. Petrarca et al. BLOOD
- Monoclonal Anti-Claudin 1 Antibodies Prevent Hepatitis C Virus Infection of Primary Human Hepatocytes
- (2010) Isabel Fofana et al. GASTROENTEROLOGY
- Long-Lasting Protective Antiviral Immunity Induced by Passive Immunotherapies Requires both Neutralizing and Effector Functions of the Administered Monoclonal Antibody
- (2010) R. Nasser et al. JOURNAL OF VIROLOGY
- A Crucial Role for Infected-Cell/Antibody Immune Complexes in the Enhancement of Endogenous Antiviral Immunity by Short Passive Immunotherapy
- (2010) Henri-Alexandre Michaud et al. PLoS Pathogens
- Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
- (2009) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-Claudin-1 associations
- (2009) Sophie E. Krieger et al. HEPATOLOGY
- Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
- (2009) L. M. Walker et al. SCIENCE
- Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against Influenza A M2 protein
- (2009) Roger R Beerli et al. Virology Journal
- A Neutralizing Human Monoclonal Antibody Protects against Lethal Disease in a New Ferret Model of Acute Nipah Virus Infection
- (2009) Katharine N. Bossart et al. PLoS Pathogens
- Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses
- (2008) P. Bruhns et al. BLOOD
- An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity
- (2008) M. Baer et al. INFECTION AND IMMUNITY
- Improvement of an Antibody Neutralizing the Anthrax Toxin by Simultaneous Mutagenesis of Its Six Hypervariable Loops
- (2008) Emmanuelle Laffly et al. JOURNAL OF MOLECULAR BIOLOGY
- Isolation of human monoclonal antibodies by mammalian cell display
- (2008) R. R. Beerli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity
- (2008) A.B.H. Bakker et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started